News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Sinha Uma
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 07/03/2023 |
4
| Sinha Uma (Director) has filed a Form 4 on PROKIDNEY CORP.|
Txns:
| Granted 48,128 options to buy
@ $10.56, valued at
$508.2k
|
|
| 07/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/24/2021 |
3
| Sinha Uma (Director) has filed a Form 3 on Social Capital Suvretta Holdings Corp. III |
| 01/28/2021 |
4
| Sinha Uma (Chief Scientific Officer) has filed a Form 4 on Eidos Therapeutics, Inc.|
Txns:
| Gifted 3,000 shares
@ $0
Unknown transaction of 303,525 shares
@ $0
Disposed/sold 60,000 options to buy
@ $13.2, valued at
$792k
|
|
| 01/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/17/2020 |
4
| Sinha Uma (Chief Scientific Officer) has filed a Form 4 on BridgeBio Pharma, Inc.|
Txns:
| Granted 8,912 options to buy
@ $3.07, valued at
$27.4k
Granted 10,832 options to buy
@ $3.07, valued at
$33.3k
Granted 5,717 options to buy
@ $42.8, valued at
$244.7k
|
|
| 12/04/2020 |
4
| Sinha Uma (Chief Scientific Officer) has filed a Form 4 on Eidos Therapeutics, Inc.|
Txns:
| Sold 3,798 shares
@ $89.6267, valued at
$340.4k
Sold 702 shares
@ $90.6339, valued at
$63.6k
Sold 300 shares
@ $91.89, valued at
$27.6k
Sold 200 shares
@ $92.965, valued at
$18.6k
|
|
| 11/18/2020 |
4
| Sinha Uma (Chief Scientific Officer) has filed a Form 4 on BridgeBio Pharma, Inc.|
Txns:
| Exercised 469 restricted stock units
@ $0 |
|
| 10/30/2020 |
4
| Sinha Uma (Chief Scientific Officer) has filed a Form 4 on Eidos Therapeutics, Inc.|
Txns:
| Sold 1,300 shares
@ $71.9024, valued at
$93.5k
Sold 3,700 shares
@ $72.6016, valued at
$268.6k
|
|
| 10/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/18/2020 |
4
| Sinha Uma (Chief Scientific Officer) has filed a Form 4 on BridgeBio Pharma, Inc.|
Txns:
| Exercised 468 restricted stock units
@ $0 |
|
| 06/05/2020 |
4
| Sinha Uma (Chief Scientific Officer) has filed a Form 4 on Eidos Therapeutics, Inc.|
Txns:
| Granted 444 shares
@ $41.5735, valued at
$18.5k
|
|
| 06/03/2020 |
4
| Sinha Uma (Chief Scientific Officer) has filed a Form 4 on BridgeBio Pharma, Inc.|
Txns:
| Granted 7,500 restricted stock units
@ $0 |
|
| 05/21/2020 |
4
| Sinha Uma (Chief Scientific Officer) has filed a Form 4 on BridgeBio Pharma, Inc.|
Txns:
| Granted 1,523 shares
@ $0
Granted 5,366 options to buy
@ $1.25, valued at
$6.7k
Granted 49,361 options to buy
@ $0.16, valued at
$7.9k
Granted 49,765 options to buy
@ $0.34, valued at
$16.9k
Granted 3,022 options to buy
@ $3.35, valued at
$10.1k
|
|
| 12/20/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/27/2019 |
4
| Sinha Uma (Chief Scientific Officer) has filed a Form 4 on Eidos Therapeutics, Inc.|
Txns:
| Sold 2,400 shares
@ $38.3756, valued at
$92.1k
Sold 100 shares
@ $39.15, valued at
$3.9k
|
|
| 07/29/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/03/2019 |
4
| Sinha Uma (Chief Scientific Officer) has filed a Form 4 on BridgeBio Pharma, Inc.|
Txns:
| Bought 14,000 shares
@ $17, valued at
$238k
|
|
| 06/27/2019 |
3
| Sinha Uma (Chief Scientific Officer) has filed a Form 3 on BridgeBio Pharma, Inc. |
| 05/28/2019 |
4
| Sinha Uma (Chief Scientific Officer) has filed a Form 4 on Eidos Therapeutics, Inc.|
Txns:
| Granted 1,081 shares
@ $12.01, valued at
$13k
Sold 4,200 shares
@ $27.16, valued at
$114.1k
Sold 800 shares
@ $27.88, valued at
$22.3k
|
|
| 11/07/2018 |
4
| Sinha Uma (Chief Scientific Officer) has filed a Form 4 on Eidos Therapeutics, Inc.|
Txns:
| Granted 60,000 options to buy
@ $13.2, valued at
$792k
|
|
| 06/19/2018 |
3
| Sinha Uma (Chief Scientific Officer) has filed a Form 3 on Eidos Therapeutics, Inc. |
|
|